388 related articles for article (PubMed ID: 33930530)
21. GPCR-mediated YAP/TAZ inactivation in fibroblasts via EPAC1/2, RAP2C, and MAP4K7.
Choi KM; Haak AJ; Diaz Espinosa AM; Cummins KA; Link PA; Aravamudhan A; Wood DK; Tschumperlin DJ
J Cell Physiol; 2021 Nov; 236(11):7759-7774. PubMed ID: 34046891
[TBL] [Abstract][Full Text] [Related]
22. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
[TBL] [Abstract][Full Text] [Related]
23. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
[TBL] [Abstract][Full Text] [Related]
24. The Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ.
Zmajkovicova K; Menyhart K; Bauer Y; Studer R; Renault B; Schnoebelen M; Bolinger M; Nayler O; Gatfield J
Am J Respir Cell Mol Biol; 2019 May; 60(5):578-591. PubMed ID: 30537446
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Jang JW; Kim MK; Bae SC
Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
[TBL] [Abstract][Full Text] [Related]
26. Multi-scale modeling of hippo signaling identifies homeostatic control by YAP-LATS negative feedback.
Sun T
Biosystems; 2021 Oct; 208():104475. PubMed ID: 34237349
[TBL] [Abstract][Full Text] [Related]
27. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
28. Hippo/YAP signaling pathway protects against neomycin-induced hair cell damage in the mouse cochlea.
Wang M; Dong Y; Gao S; Zhong Z; Cheng C; Qiang R; Zhang Y; Shi X; Qian X; Gao X; Guan B; Yu C; Yu Y; Chai R
Cell Mol Life Sci; 2022 Jan; 79(2):79. PubMed ID: 35044530
[TBL] [Abstract][Full Text] [Related]
29. Combined control of the fibroblast contractile program by YAP and TAZ.
Link PA; Choi KM; Diaz Espinosa AM; Jones DL; Gao AY; Haak AJ; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2022 Jan; 322(1):L23-L32. PubMed ID: 34755530
[TBL] [Abstract][Full Text] [Related]
30. The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2.
Yang WH; Lin CC; Wu J; Chao PY; Chen K; Chen PH; Chi JT
Mol Cancer Res; 2021 Jun; 19(6):1005-1014. PubMed ID: 33707306
[TBL] [Abstract][Full Text] [Related]
31. Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis.
Boopathy GTK; Hong W
Front Cell Dev Biol; 2019; 7():49. PubMed ID: 31024911
[TBL] [Abstract][Full Text] [Related]
32. Dynamic Hippo pathway activity underlies mesenchymal differentiation during lung alveolar morphogenesis.
Chaudhry FN; Michki NS; Shirmer DL; McGrath-Morrow S; Young LR; Frank DB; Zepp JA
Development; 2024 Apr; 151(8):. PubMed ID: 38602485
[TBL] [Abstract][Full Text] [Related]
33. Roles of Hippo-YAP/TAZ signalling in intervertebral disc degeneration.
Zheng-Wei S; Yuan T; Chao-Shuai F; Lei Z; Zong-Rang S; Tuan-Jiang L; Ding-Jun H
Biomed Pharmacother; 2023 Mar; 159():114099. PubMed ID: 36641923
[TBL] [Abstract][Full Text] [Related]
34. YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways.
Zhu T; Ma Z; Wang H; Jia X; Wu Y; Fu L; Li Z; Zhang C; Yu G
Mol Cell Biochem; 2020 Dec; 475(1-2):137-149. PubMed ID: 32813142
[TBL] [Abstract][Full Text] [Related]
35. Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway.
Kong D; Jiang Y; Miao X; Wu Z; Liu H; Gong W
Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166267. PubMed ID: 34508829
[TBL] [Abstract][Full Text] [Related]
36. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function.
Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS
Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555
[TBL] [Abstract][Full Text] [Related]
37. Yes-associated protein reacts differently in vascular smooth muscle cells under different intensities of mechanical stretch.
Wang X; Liang X; Zhou L; Liu S; Fang Z; Hu C; Hou Y; Guo Z
Aging (Albany NY); 2022 Jan; 14(1):286-296. PubMed ID: 34983026
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
[TBL] [Abstract][Full Text] [Related]
39. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
Miesfeld JB; Link BA
Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
[TBL] [Abstract][Full Text] [Related]
40. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
